A citation-based method for searching scientific literature

Andrew R Davies, James A Gossage, Janine Zylstra, Fredrik Mattsson, Jesper Lagergren, Nick Maisey, Elizabeth C Smyth, David Cunningham, William H Allum, Robert C Mason. J Clin Oncol 2014
Times Cited: 167







List of co-cited articles
408 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.
David Cunningham, William H Allum, Sally P Stenning, Jeremy N Thompson, Cornelis J H Van de Velde, Marianne Nicolson, J Howard Scarffe, Fiona J Lofts, Stephen J Falk, Timothy J Iveson,[...]. N Engl J Med 2006
48

Preoperative chemoradiotherapy for esophageal or junctional cancer.
P van Hagen, M C C M Hulshof, J J B van Lanschot, E W Steyerberg, M I van Berge Henegouwen, B P L Wijnhoven, D J Richel, G A P Nieuwenhuijzen, G A P Hospers, J J Bonenkamp,[...]. N Engl J Med 2012
38

Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.
Marc Ychou, Valérie Boige, Jean-Pierre Pignon, Thierry Conroy, Olivier Bouché, Gilles Lebreton, Muriel Ducourtieux, Laurent Bedenne, Jean-Michel Fabre, Bernard Saint-Aubert,[...]. J Clin Oncol 2011
29

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.
Joel Shapiro, J Jan B van Lanschot, Maarten C C M Hulshof, Pieter van Hagen, Mark I van Berge Henegouwen, Bas P L Wijnhoven, Hanneke W M van Laarhoven, Grard A P Nieuwenhuijzen, Geke A P Hospers, Johannes J Bonenkamp,[...]. Lancet Oncol 2015
20

Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations.
A M Mandard, F Dalibard, J C Mandard, J Marnay, M Henry-Amar, J F Petiot, A Roussel, J H Jacob, P Segol, G Samama. Cancer 1994
17

Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial.
Elizabeth C Smyth, Matteo Fassan, David Cunningham, William H Allum, Alicia F C Okines, Andrea Lampis, Jens C Hahne, Massimo Rugge, Clare Peckitt, Matthew Nankivell,[...]. J Clin Oncol 2016
160
17



Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer.
William H Allum, Sally P Stenning, John Bancewicz, Peter I Clark, Ruth E Langley. J Clin Oncol 2009
668
14

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.
Florian Lordick, Katja Ott, Bernd-Joachim Krause, Wolfgang A Weber, Karen Becker, Hubert J Stein, Sylvie Lorenzen, Tibor Schuster, Hinrich Wieder, Ken Herrmann,[...]. Lancet Oncol 2007
574
13

Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas.
T Schmidt, L Sicic, S Blank, K Becker, W Weichert, T Bruckner, T Parakonthun, R Langer, M W Büchler, J-R Siewert,[...]. Br J Cancer 2014
82
15

Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases.
Karen Becker, Rupert Langer, Daniel Reim, Alexander Novotny, Christian Meyer zum Buschenfelde, Jutta Engel, Helmut Friess, Heinz Hofler. Ann Surg 2011
204
13

Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy.
Karen Becker, James D Mueller, Christoph Schulmacher, Katja Ott, Ulrich Fink, Raymonde Busch, Knut Böttcher, J Rüdiger Siewert, Heinz Höfler. Cancer 2003
473
12

Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma.
F Noble, M A Lloyd, R Turkington, E Griffiths, M O'Donovan, J R O'Neill, S Mercer, S L Parsons, R C Fitzgerald, T J Underwood. Br J Surg 2017
67
16

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
11

Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas.
Rupert Langer, Katja Ott, Marcus Feith, Florian Lordick, Jörg-Rüdiger Siewert, Karen Becker. Mod Pathol 2009
88
11

Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.
Christoph Schuhmacher, Stephan Gretschel, Florian Lordick, Peter Reichardt, Werner Hohenberger, Claus F Eisenberger, Cornelie Haag, Murielle E Mauer, Baktiar Hasan, John Welch,[...]. J Clin Oncol 2010
451
10

Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.
Katja Ott, Wolfgang A Weber, Florian Lordick, Karen Becker, Raymonde Busch, Ken Herrmann, Hinrich Wieder, Ulrich Fink, Markus Schwaiger, Jörg-Rüdiger Siewert. J Clin Oncol 2006
360
9

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.
Katrin M Sjoquist, Bryan H Burmeister, B Mark Smithers, John R Zalcberg, R John Simes, Andrew Barbour, Val Gebski. Lancet Oncol 2011
9

Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation.
Lucian R Chirieac, Stephen G Swisher, Jaffer A Ajani, Ritsuko R Komaki, Arlene M Correa, Jeffrey S Morris, Jack A Roth, Asif Rashid, Stanley R Hamilton, Tsung-Teh Wu. Cancer 2005
346
8

A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.
T N Walsh, N Noonan, D Hollywood, A Kelly, N Keeling, T P Hennessy. N Engl J Med 1996
8

Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction.
Michael Stahl, Martin K Walz, Martin Stuschke, Nils Lehmann, Hans-Joachim Meyer, Jorge Riera-Knorrenschild, Peter Langer, Rita Engenhart-Cabillic, Michael Bitzer, Alfred Königsrainer,[...]. J Clin Oncol 2009
640
8

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.
Joel Tepper, Mark J Krasna, Donna Niedzwiecki, Donna Hollis, Carolyn E Reed, Richard Goldberg, Krystyna Kiel, Christopher Willett, David Sugarbaker, Robert Mayer. J Clin Oncol 2008
957
8

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
J S Macdonald, S R Smalley, J Benedetti, S A Hundahl, N C Estes, G N Stemmermann, D G Haller, J A Ajani, L L Gunderson, J M Jessup,[...]. N Engl J Med 2001
8

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.
Yung-Jue Bang, Young-Woo Kim, Han-Kwang Yang, Hyun Cheol Chung, Young-Kyu Park, Kyung Hee Lee, Keun-Wook Lee, Yong Ho Kim, Sang-Ik Noh, Jae Yong Cho,[...]. Lancet 2012
8

Prognostic classification of histopathologic response to neoadjuvant therapy in esophageal adenocarcinoma.
Arnulf H Hölscher, Uta Drebber, Henner Schmidt, Efriede Bollschweiler. Ann Surg 2014
51
13

Oesophageal cancer.
Jesper Lagergren, Elizabeth Smyth, David Cunningham, Pernilla Lagergren. Lancet 2017
527
7

Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials.
Vera Oppedijk, Ate van der Gaast, Jan J B van Lanschot, Pieter van Hagen, Rob van Os, Caroline M van Rij, Maurice J van der Sangen, Jannet C Beukema, Heidi Rütten, Patty H Spruit,[...]. J Clin Oncol 2014
298
7


Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial.
David Cunningham, Sally P Stenning, Elizabeth C Smyth, Alicia F Okines, William H Allum, Sam Rowley, Laura Stevenson, Heike I Grabsch, Derek Alderson, Thomas Crosby,[...]. Lancet Oncol 2017
167
7

Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial.
Elizabeth C Smyth, Andrew Wotherspoon, Clare Peckitt, David Gonzalez, Sanna Hulkki-Wilson, Zakaria Eltahir, Matteo Fassan, Massimo Rugge, Nicola Valeri, Alicia Okines,[...]. JAMA Oncol 2017
264
7

7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction.
Thomas W Rice, Eugene H Blackstone, Valerie W Rusch. Ann Surg Oncol 2010
636
6

Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer.
Claus Rödel, Peter Martus, Thomas Papadoupolos, Laszlo Füzesi, Martin Klimpfinger, Rainer Fietkau, Torsten Liersch, Werner Hohenberger, Rudolf Raab, Rolf Sauer,[...]. J Clin Oncol 2005
924
6

Global incidence of oesophageal cancer by histological subtype in 2012.
Melina Arnold, Isabelle Soerjomataram, Jacques Ferlay, David Forman. Gut 2015
826
6


Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer.
Mitsuru Sasako, Shinichi Sakuramoto, Hitoshi Katai, Taira Kinoshita, Hiroshi Furukawa, Toshiharu Yamaguchi, Atsushi Nashimoto, Masashi Fujii, Toshifusa Nakajima, Yasuo Ohashi. J Clin Oncol 2011
912
6

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial.
Sung Hoon Noh, Sook Ryun Park, Han-Kwang Yang, Hyun Cheol Chung, Ik-Joo Chung, Sang-Woon Kim, Hyung-Ho Kim, Jin-Hyuk Choi, Hoon-Kyo Kim, Wansik Yu,[...]. Lancet Oncol 2014
607
6

Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging.
W A Weber, K Ott, K Becker, H J Dittler, H Helmberger, N E Avril, G Meisetschläger, R Busch, J R Siewert, M Schwaiger,[...]. J Clin Oncol 2001
543
6

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Yung-Jue Bang, Eric Van Cutsem, Andrea Feyereislova, Hyun C Chung, Lin Shen, Akira Sawaki, Florian Lordick, Atsushi Ohtsu, Yasushi Omuro, Taroh Satoh,[...]. Lancet 2010
6

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
E C Smyth, M Verheij, W Allum, D Cunningham, A Cervantes, D Arnold. Ann Oncol 2016
865
6

Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
F Lordick, C Mariette, K Haustermans, R Obermannová, D Arnold. Ann Oncol 2016
545
6



Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT).
Stephen G Swisher, Wayne Hofstetter, Tsung T Wu, Arlene M Correa, Jaffer A Ajani, Ritsuko R Komaki, Lucian Chirieac, Kelly K Hunt, Zhongxing Liao, Alexandria Phan,[...]. Ann Surg 2005
130
6

Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.
Bryan M Burt, Shawn S Groth, Yvonne H Sada, Farhood Farjah, Lorraine Cornwell, David J Sugarbaker, Nader N Massarweh. Ann Surg 2017
63
9

The role of adjuvant platinum-based chemotherapy in esophagogastric cancer patients who received neoadjuvant chemotherapy prior to definitive surgery.
John H Saunders, Christopher R Bowman, Alex M Reece-Smith, Vincent Pang, Matthew S Dorrington, Errum Mumtaz, Irshad Soomro, Philip Kaye, Srinivasan Madhusudan, Simon L Parsons. J Surg Oncol 2017
23
26

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E A Eisenhauer, P Therasse, J Bogaerts, L H Schwartz, D Sargent, R Ford, J Dancey, S Arbuck, S Gwyther, M Mooney,[...]. Eur J Cancer 2009
6

Guidelines for the management of oesophageal and gastric cancer.
William H Allum, Jane M Blazeby, S Michael Griffin, David Cunningham, Janusz A Jankowski, Rachel Wong. Gut 2011
378
6

Lymph node regression and survival following neoadjuvant chemotherapy in oesophageal adenocarcinoma.
A R Davies, D Myoteri, J Zylstra, C R Baker, W Wulaningsih, M Van Hemelrijck, N Maisey, W H Allum, E Smyth, J A Gossage,[...]. Br J Surg 2018
35
17

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.